UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Possible impact of the diabatic heating over the Indian subcontinent on heat waves in South Korea

International journal of climatology, 2019-03, Vol.39 (3), p.1166-1180

2019

Volltextzugriff (PDF)

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer

Scientific reports, 2023-10, Vol.13 (1), p.18126-18126, Article 18126

2023

Volltextzugriff (PDF)

Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study

PloS one, 2022-12, Vol.17 (12), p.e0278610-e0278610

2022

Volltextzugriff (PDF)

Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness

PloS one, 2021-02, Vol.16 (2), p.e0246296-e0246296

2021

Volltextzugriff (PDF)

Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea

Cancer medicine (Malden, MA), 2021-09, Vol.10 (17), p.5809-5822

2021

Volltextzugriff (PDF)

Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)

Cancers, 2023-11, Vol.15 (23), p.5568

2023

Volltextzugriff (PDF)

Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum‐based doublet chemotherapy and immunotherapy (SPACE study)

Thoracic cancer, 2021-04, Vol.12 (8), p.1264-1268

2021

Volltextzugriff (PDF)

Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study

Thoracic cancer, 2023-09, Vol.14 (27), p.2777-2784

2023

Volltextzugriff (PDF)

Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea

Thoracic cancer, 2024-02, Vol.15 (6), p.448-457

2024

Volltextzugriff (PDF)

A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer

Cancers, 2023-03, Vol.15 (5), p.1606

2023

Volltextzugriff (PDF)

Microbiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in Korea

PloS one, 2016-08, Vol.11 (8), p.e0161280-e0161280

2016

Volltextzugriff (PDF)

Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer

Cancers, 2023-02, Vol.15 (4), p.1151

2023

Volltextzugriff (PDF)

Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer

Thoracic cancer, 2020-02, Vol.11 (2), p.408-414

2020

Volltextzugriff (PDF)

Association between Weight Change and Incidence of Dyslipidemia in Young Adults: A Retrospective Cohort Study of Korean Male Soldiers

Journal of Obesity & Metabolic Syndrome, 2024, 33(1), 111, pp.36-44

2024

Volltextzugriff (PDF)

Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report

BMC pulmonary medicine, 2020-03, Vol.20 (1), p.71-71, Article 71

2020

Volltextzugriff (PDF)

Superior vena cava syndrome with extensive collateral vessels

Thoracic cancer, 2019-12, Vol.10 (12), p.2322-2322

2019

Volltextzugriff (PDF)

Myasthenia gravis and myopathy after nivolumab treatment for non‐small cell lung carcinoma: A case report

Thoracic cancer, 2019-10, Vol.10 (10), p.2045-2049

2019

Volltextzugriff (PDF)

Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid‐Lung‐A

Thoracic cancer, 2021-02, Vol.12 (4), p.444-452

2021

Volltextzugriff (PDF)

Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer

Thoracic cancer, 2018-07, Vol.9 (7), p.856-864

2018

Volltextzugriff (PDF)

Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial

Cells (Basel, Switzerland), 2023-04, Vol.12 (9), p.1246

2023

Volltextzugriff (PDF)

Risk factors for primary lung cancer among never-smoking women in South Korea: a retrospective nationwide population-based cohort study

The Korean journal of internal medicine, 2020-05, Vol.35 (3), p.692-702

2020

Volltextzugriff (PDF)

Potentially fatal complications of systemic air embolism after computed tomography‐guided transthoracic needle biopsy in lung cancer harboring epithelial growth factor receptor mutation: A case report

Thoracic cancer, 2020-11, Vol.11 (11), p.3401-3406

2020

Volltextzugriff (PDF)

Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer

Thoracic cancer, 2019-04, Vol.10 (4), p.942-949

2019

Volltextzugriff (PDF)

MicroRNA-124 regulates osteoclast differentiation

Bone (New York, N.Y.), 2013-10, Vol.56 (2), p.383-389

2013

Volltextzugriff (PDF)

Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non–Small-cell Lung Cancer: A TRAIL Trial

Clinical lung cancer, 2017-07, Vol.18 (4), p.e289-e296

2017

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Englisch
(171)
Japanisch
(12)
Koreanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(99)
Humans
(54)
Oncology
(45)
Female
(40)
Male
(40)
Middle Aged
(33)
Lung Cancer
(32)
Aged
(30)
Original
(28)
Respiratory System
(28)
Chemotherapy
(22)
Mutation
(22)
Patients
(21)
Cancer Therapies
(20)
Physical Sciences
(19)
Lung Neoplasms - Drug Therapy
(17)
Technology
(17)
Adult
(16)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Possible impact of the diabatic heating over the Indian subcontinent on heat waves in South Korea

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer

Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study

Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness

Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea

Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study)

Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum‐based doublet chemotherapy and immunotherapy (SPACE study)

Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study

Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea

A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer

Microbiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in Korea

Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer

Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer

Association between Weight Change and Incidence of Dyslipidemia in Young Adults: A Retrospective Cohort Study of Korean Male Soldiers

Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report

Superior vena cava syndrome with extensive collateral vessels

Myasthenia gravis and myopathy after nivolumab treatment for non‐small cell lung carcinoma: A case report

Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid‐Lung‐A

Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer

Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial

Risk factors for primary lung cancer among never-smoking women in South Korea: a retrospective nationwide population-based cohort study

Potentially fatal complications of systemic air embolism after computed tomography‐guided transthoracic needle biopsy in lung cancer harboring epithelial growth factor receptor mutation: A case report

Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer

MicroRNA-124 regulates osteoclast differentiation

Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non–Small-cell Lung Cancer: A TRAIL Trial

Suchergebnisse filtern